Extended Access of Momelotinib in Adults With Myelofibrosis

NCT03441113 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Post-polycythemia Vera Myelofibrosis (Post-PV MF)
Primary Myelofibrosis (PMF)
Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Primary Myelofibrosis

Interventions

DRUG: MMB

Sponsor

GlaxoSmithKline